DFP Healthcare Acquisitions Cor DFPH OTC · Consumer defensive · Taiwan
$2.01 +0.00% +$0.00
Summary
26 / 100 · Bulios Score
What speaks for it
- It holds more cash than debt: $36.9M against $25.2M.
- Out of every 100 USD of revenue, 9.7 USD is left as free cash.
What to watch
- The company made a loss over the last 12 months.
- The share price is above the Bulios Fair Price.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBy our assumptions the business is worth less than its shares cost today.
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
Revenue (USD)
There is not enough revenue history yet to say how fast it grows.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $16.4M.
Profitability in detailIs it financially healthy?
YesRepaying all its debt would take 1.5 years of free cash flow. It holds more cash than debt. The debt score is low because of the debt-to-equity ratio.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Health Care, Patient Service 50%
- Fee For Service 32%
- Capitated Revenue 17%
- Clinical Research Trials And Other Revenue 1.0%
By region
The company reports no revenue by region.
Health Care, Patient Service brings in 50% of revenue.
Segments in detail